Quest Diagnostics Incorporated (0KSX.L)
USD 173.4
(5.91%)
USD 173.4
(5.91%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.96 Billion USD | -13.75% |
| 2022 | 3.43 Billion USD | -18.44% |
| 2021 | 4.2 Billion USD | 15.85% |
| 2020 | 3.63 Billion USD | 35.11% |
| 2019 | 2.68 Billion USD | 3.22% |
| 2018 | 2.6 Billion USD | -12.88% |
| 2017 | 2.99 Billion USD | 3.14% |
| 2016 | 2.89 Billion USD | 2.22% |
| 2015 | 2.83 Billion USD | 1.36% |
| 2014 | 2.79 Billion USD | -0.78% |
| 2013 | 2.82 Billion USD | -6.56% |
| 2012 | 3.01 Billion USD | -3.12% |
| 2011 | 3.11 Billion USD | 2.08% |
| 2010 | 3.05 Billion USD | -2.62% |
| 2009 | 3.13 Billion USD | 4.69% |
| 2008 | 2.99 Billion USD | 9.44% |
| 2007 | 2.73 Billion USD | 6.31% |
| 2006 | 2.57 Billion USD | 14.52% |
| 2005 | 2.24 Billion USD | 5.17% |
| 2004 | 2.13 Billion USD | 8.46% |
| 2003 | 1.96 Billion USD | 17.53% |
| 2002 | 1.67 Billion USD | 13.51% |
| 2001 | 1.47 Billion USD | 1.56% |
| 2000 | 1.45 Billion USD | 64.02% |
| 1999 | 886.2 Million USD | 37.46% |
| 1998 | 644.7 Million USD | -1.3% |
| 1997 | 653.2 Million USD | 7.89% |
| 1996 | 605.42 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 755 Million USD | 2.03% |
| 2024 Q3 | 811 Million USD | 4.51% |
| 2024 Q2 | 776 Million USD | 2.78% |
| 2023 Q4 | 740 Million USD | -1.86% |
| 2023 Q1 | 771 Million USD | 1.72% |
| 2023 FY | 2.96 Billion USD | -13.75% |
| 2023 Q2 | 792 Million USD | 2.72% |
| 2023 Q3 | 754 Million USD | -4.8% |
| 2022 FY | 3.43 Billion USD | -18.44% |
| 2022 Q1 | 965 Million USD | -5.95% |
| 2022 Q2 | 842 Million USD | -12.75% |
| 2022 Q3 | 868 Million USD | 3.09% |
| 2022 Q4 | 758 Million USD | -12.67% |
| 2021 Q4 | 1.02 Billion USD | -7.07% |
| 2021 FY | 4.2 Billion USD | 15.85% |
| 2021 Q1 | 1.09 Billion USD | -13.79% |
| 2021 Q2 | 985 Million USD | -9.96% |
| 2021 Q3 | 1.1 Billion USD | 12.08% |
| 2020 Q2 | 606 Million USD | 9.78% |
| 2020 Q3 | 1.2 Billion USD | 99.01% |
| 2020 Q4 | 1.26 Billion USD | 5.22% |
| 2020 Q1 | 552 Million USD | -16.62% |
| 2020 FY | 3.63 Billion USD | 35.11% |
| 2019 Q1 | 647 Million USD | 7.12% |
| 2019 Q4 | 662 Million USD | -4.34% |
| 2019 FY | 2.68 Billion USD | 3.22% |
| 2019 Q2 | 688 Million USD | 6.34% |
| 2019 Q3 | 692 Million USD | 0.58% |
| 2018 Q2 | 676 Million USD | 2.74% |
| 2018 Q3 | 667 Million USD | -1.33% |
| 2018 FY | 2.6 Billion USD | -12.88% |
| 2018 Q1 | 658 Million USD | -11.32% |
| 2018 Q4 | 604 Million USD | -9.45% |
| 2017 Q1 | 734 Million USD | 4.71% |
| 2017 Q4 | 742 Million USD | 0.13% |
| 2017 Q3 | 741 Million USD | -4.14% |
| 2017 FY | 2.99 Billion USD | 3.14% |
| 2017 Q2 | 773 Million USD | 5.31% |
| 2016 FY | 2.89 Billion USD | 2.22% |
| 2016 Q3 | 728 Million USD | -3.06% |
| 2016 Q2 | 751 Million USD | 4.45% |
| 2016 Q1 | 719 Million USD | 2.86% |
| 2016 Q4 | 701 Million USD | -3.71% |
| 2015 FY | 2.83 Billion USD | 1.36% |
| 2015 Q4 | 699 Million USD | -2.65% |
| 2015 Q3 | 718 Million USD | -3.36% |
| 2015 Q2 | 743 Million USD | 9.91% |
| 2015 Q1 | 676 Million USD | -3.29% |
| 2014 FY | 2.79 Billion USD | -0.78% |
| 2014 Q2 | 728 Million USD | 12.87% |
| 2014 Q1 | 645 Million USD | -8.51% |
| 2014 Q3 | 726 Million USD | -0.27% |
| 2014 Q4 | 699 Million USD | -3.72% |
| 2013 FY | 2.82 Billion USD | -6.56% |
| 2013 Q4 | 705 Million USD | 0.92% |
| 2013 Q3 | 698.6 Million USD | -3.24% |
| 2013 Q2 | 722 Million USD | 3.91% |
| 2013 Q1 | 694.8 Million USD | -0.91% |
| 2012 Q3 | 761.7 Million USD | -4.35% |
| 2012 Q4 | 701.2 Million USD | -7.94% |
| 2012 Q2 | 796.3 Million USD | -2.89% |
| 2012 Q1 | 820 Million USD | 2.25% |
| 2012 FY | 3.01 Billion USD | -3.12% |
| 2011 Q2 | 798.8 Million USD | 10.24% |
| 2011 Q4 | 801.94 Million USD | 1.54% |
| 2011 Q3 | 789.8 Million USD | -1.13% |
| 2011 FY | 3.11 Billion USD | 2.08% |
| 2011 Q1 | 724.6 Million USD | -2.56% |
| 2010 Q1 | 739.1 Million USD | -5.0% |
| 2010 FY | 3.05 Billion USD | -2.62% |
| 2010 Q2 | 795.8 Million USD | 7.67% |
| 2010 Q3 | 773.2 Million USD | -2.84% |
| 2010 Q4 | 743.6 Million USD | -3.83% |
| 2009 FY | 3.13 Billion USD | 4.69% |
| 2009 Q1 | 754.51 Million USD | -0.64% |
| 2009 Q4 | 778.03 Million USD | -2.71% |
| 2009 Q3 | 799.7 Million USD | -0.24% |
| 2009 Q2 | 801.6 Million USD | 6.24% |
| 2008 Q4 | 759.38 Million USD | 0.78% |
| 2008 Q3 | 753.48 Million USD | -0.12% |
| 2008 FY | 2.99 Billion USD | 9.44% |
| 2008 Q1 | 726.01 Million USD | -0.24% |
| 2008 Q2 | 754.42 Million USD | 3.91% |
| 2007 Q1 | 594.42 Million USD | -5.63% |
| 2007 Q4 | 727.75 Million USD | -1.72% |
| 2007 Q3 | 740.47 Million USD | 10.12% |
| 2007 Q2 | 672.41 Million USD | 13.12% |
| 2007 FY | 2.73 Billion USD | 6.31% |
| 2006 FY | 2.57 Billion USD | 14.52% |
| 2006 Q4 | 629.85 Million USD | -3.02% |
| 2006 Q3 | 649.46 Million USD | 0.24% |
| 2006 Q2 | 647.9 Million USD | 2.45% |
| 2006 Q1 | 632.42 Million USD | 12.27% |
| 2005 Q2 | 578.85 Million USD | 7.31% |
| 2005 Q1 | 539.4 Million USD | 2.58% |
| 2005 Q4 | 563.32 Million USD | -0.26% |
| 2005 Q3 | 564.8 Million USD | -2.43% |
| 2005 FY | 2.24 Billion USD | 5.17% |
| 2004 Q2 | 539.47 Million USD | 4.05% |
| 2004 FY | 2.13 Billion USD | 8.46% |
| 2004 Q3 | 541.47 Million USD | 0.37% |
| 2004 Q1 | 518.46 Million USD | 4.15% |
| 2004 Q4 | 525.85 Million USD | -2.88% |
| 2003 Q3 | 510.04 Million USD | -1.31% |
| 2003 Q4 | 497.78 Million USD | -2.4% |
| 2003 Q2 | 516.81 Million USD | 16.22% |
| 2003 FY | 1.96 Billion USD | 17.53% |
| 2003 Q1 | 444.7 Million USD | 7.3% |
| 2002 Q3 | 433.63 Million USD | -1.12% |
| 2002 FY | 1.67 Billion USD | 13.51% |
| 2002 Q1 | 389.02 Million USD | 4.33% |
| 2002 Q2 | 438.55 Million USD | 12.73% |
| 2002 Q4 | 414.44 Million USD | -4.43% |
| 2001 Q3 | 367.62 Million USD | -3.81% |
| 2001 Q4 | 372.86 Million USD | 1.43% |
| 2001 FY | 1.47 Billion USD | 1.56% |
| 2001 Q1 | 387.75 Million USD | 14.06% |
| 2001 Q2 | 382.19 Million USD | -1.43% |
| 2000 Q2 | 387.91 Million USD | 10.93% |
| 2000 Q3 | 376 Million USD | -3.07% |
| 2000 Q1 | 349.68 Million USD | 25.56% |
| 2000 FY | 1.45 Billion USD | 64.02% |
| 2000 Q4 | 339.95 Million USD | -9.59% |
| 1999 Q3 | 261.7 Million USD | 45.63% |
| 1999 Q1 | 166.2 Million USD | 3.42% |
| 1999 Q2 | 179.7 Million USD | 8.12% |
| 1999 FY | 886.2 Million USD | 37.46% |
| 1999 Q4 | 278.5 Million USD | 6.42% |
| 1998 Q4 | 160.7 Million USD | -0.5% |
| 1998 Q1 | 161.8 Million USD | 2.21% |
| 1998 Q2 | 160.7 Million USD | -0.68% |
| 1998 Q3 | 161.5 Million USD | 0.5% |
| 1998 FY | 644.7 Million USD | -1.3% |
| 1997 Q4 | 158.3 Million USD | 0.64% |
| 1997 Q1 | 162.4 Million USD | 13.65% |
| 1997 Q2 | 175.1 Million USD | 7.82% |
| 1997 Q3 | 157.3 Million USD | -10.17% |
| 1997 FY | 653.2 Million USD | 7.89% |
| 1996 Q4 | 142.9 Million USD | -4.73% |
| 1996 Q3 | 150 Million USD | 0.0% |
| 1996 FY | 605.42 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -1367.694% |
| Accuray Incorporated | 143.12 Million USD | -1968.879% |
| Align Technology, Inc. | 2.72 Billion USD | -8.854% |
| Elevance Health Inc. | 47.01 Billion USD | 93.701% |
| AxoGen, Inc. | 127.87 Million USD | -2215.561% |
| Boston Scientific Corporation | 9.84 Billion USD | 69.936% |
| CVS Health Corporation | 54.43 Billion USD | 94.56% |
| Cardinal Health, Inc. | 7.41 Billion USD | 60.062% |
| Centene Corporation | 153.99 Billion USD | 98.077% |
| DaVita Inc. | 3.82 Billion USD | 22.496% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 94.623% |
| Hologic, Inc. | 2.23 Billion USD | -32.317% |
| Humana Inc. | 106.44 Billion USD | 97.218% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -35.207% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | 12.003% |
| Masimo Corporation | 1 Billion USD | -195.067% |
| McKesson Corporation | 12.58 Billion USD | 76.47% |
| Patterson Companies, Inc. | 1.38 Billion USD | -114.528% |
| ResMed Inc. | 2.6 Billion USD | -13.501% |
| Henry Schein, Inc. | 3.65 Billion USD | 18.899% |
| Teladoc Health, Inc. | 1.84 Billion USD | -60.716% |
| Universal Health Services, Inc. | 1.17 Billion USD | -151.918% |
| Veeva Systems Inc. | 1.68 Billion USD | -75.583% |
| Baxter International Inc. | 4.97 Billion USD | 40.482% |
| Becton, Dickinson and Company | 8.82 Billion USD | 66.44% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 37.393% |
| Danaher Corporation | 14.12 Billion USD | 79.043% |
| Stryker Corporation | 13.05 Billion USD | 77.324% |
| Medtronic plc | 21.27 Billion USD | 86.081% |